FOLLOW-UP RECOMMENDATIONS
- For outpatient treatment the team must establish modest goals and clear parameters, including expected weight gain for anorexic patients and compliance with follow-up appointments.
- Internist/pediatrician: Monitor vital signs, weight, BMI, electrolytes, and ECG.
- Nutritionist: Monitor diet, calorie intake, and exercise.
- Psychotherapy:
- Cognitive behavioral therapy and interpersonal psychotherapy are the most effective forms of psychotherapy for BN.
- Cognitive behavioral therapy, family therapy, and psychodynamic therapies are all useful for AN.
- Family-based treatment is the preferred therapy for teenagers with AN, and it is promising for teenagers with BN as well.
- Pharmacotherapy:
- Only indicated within the context of psychotherapy, especially with comorbid psychopathology.
- No accepted pharmacologic treatment of AN.
- Case studies suggest that 2nd-generation antipsychotics may be helpful in AN.
- There is no clear evidence for specific treatment of osteoporosis in AN apart from weight restoration and nutritional calcium supplementation.
- Antidepressant medications are shown to significantly reduce bingeing and purging behaviors:
- Fluoxetine is the best studied
PEARLS AND PITFALLS
- Eating disorders are associated with high medical risk and risk of suicide; prioritize safety assessment
- Rapid restoration of nutrition, volume resuscitation, and/or failure to replete vitamins and electrolytes can result in potentially fatal refeeding syndrome
- Avoid trying to “out-obsess” the obsessional patient
- Coordinate care with PCP and other members of a multidisciplinary team
ADDITIONAL READING
- Aigner M, Treasure J, Kaye W, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.
World J Biol Psychiatry.
2011;12:400–443.
- American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders
. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
- American Psychiatric Association (APA).
Practice Guidelines for the Treatment of Patients with Eating Disorders
. 3rd ed. Washington, DC: 2006, and Guideline Watch (update) August 2012.
- Mascolo M, Trent S, Colwell C, et al. What the emergency department needs to know when caring for your patients with eating disorders.
Int J Eat Disord.
2012;45:977–981.
- Mitchell JE, Crow S. Medical complications of anorexia nervosa and bulimia nervosa.
Curr Opin Psychiatry
. 2006;19(4):438–443.
- Rosen DS, American Academy of Pediatrics Committee on Adolescence. Identification and management of eating disorders in children and adolescents.
Pediatrics
. 2010;126:1240–1253.
CODES
ICD9
- 307.1 Anorexia nervosa
- 307.50 Eating disorder, unspecified
- 307.51 Bulimia nervosa
ICD10
- F50.00 Anorexia nervosa, unspecified
- F50.2 Bulimia nervosa
- F50.9 Eating disorder, unspecified
ECTOPIC PREGNANCY
Ivette Motola
•
Aviva Jacoby Zigman
BASICS
DESCRIPTION
- Implantation of fertilized ovum outside of uterus:
- Most commonly fallopian tube (93–97%)
- Abdominal and peritoneal implantations:
- Associated with higher morbidity
- Difficulty in diagnosis
- Tendency to bleed
- Occurs in 2–2.6% of pregnancies
- Accounts for 6% of all maternal deaths (leading cause of 1st-trimester pregnancy-related death)
- 60% of women with ectopic pregnancy are subsequently able to have a normal pregnancy
ETIOLOGY
- Risk factors include:
- Woman >35 yr old
- African American
- Previous fallopian tube damage from infections, such as pelvic inflammatory disease (PID)
- Previous tubal surgery (i.e., tubal ligation)
- Previous ectopic pregnancy
- Intrauterine device (IUD) use:
- 25–50% of pregnancies with IUD are ectopic
- Diethylstilbestrol (DES) exposure
- In vitro fertilizations
- Being a current smoker
- More than half of women with ectopic pregnancies have no risk factors
DIAGNOSIS
SIGNS AND SYMPTOMS
Classic triad of amenorrhea, vaginal bleeding, and abdominal pain are present in only 15% of women with ectopic pregnancies:
- Amenorrhea (75–95%)
- Abdominal pain (80–100%):
- Abnormal vaginal bleeding (50–80%)
- Symptoms of pregnancy (10–25%)
- Orthostatic hypotension, dizziness, and syncope (5–35%)
- Abdominal tenderness (55–95%)
- Adnexal tenderness (75–90%)
- Adnexal mass (35–50%)
- Cervical motion tenderness (43%)
History
- Last menstrual period (LMP):
- Majority of ectopics present 5–8 wk after LMP.
- Gestation and parity history
- Vaginal bleeding
- Location, nature, and severity of pain
- History of pelvic surgery, prior ectopic, IUD
- History of fertility treatments
Physical-Exam
- Evaluate for signs of peritoneal irritation
- Pelvic exam:
- Note uterine size
- Adnexal size, mass
- Adnexal tenderness
- Presence of tissue in vaginal vault
- Cervical motion tenderness
- Cervical OS open or closed
ESSENTIAL WORKUP
- Pregnancy testing:
- Women of potential childbearing age with vaginal bleeding or abdominal pain
must
have urine or serum pregnancy test
- Include testing of patients with history of recent elective or spontaneous abortion, tubal ligations, or IUD use
- Quantitative β-human chorionic gonadotropin (β-hCG) in patients with positive qualitative test
- Vital signs unstable:
- 2 large-bore IVs
- Type and cross-match, hemoglobin (Hg)/hematocrit (Hct)
- Bedside ultrasound (US), if immediately available, simultaneous with resuscitation (transvaginal preferred)
- Consult obstetrics/gynecology (OB/GYN) and prepare for immediate surgical intervention
- Vital signs stable:
- Rapid Hg/Hct determination
- Type and Rh
- US (transvaginal preferred)
DIAGNOSIS TESTS & NTERPRETATION
Lab
- Urine pregnancy tests can detect β-hCG levels of 25–50 mIU/L
- Serum can detect β-hCG levels of 25 mIU/L
- Quantitative serum β-hCG; for diagnosis and follow-up:
- Doubles every 2 days in normal early pregnancy (early pregnancy <10,000 β-hCG mIU/L, 8 days–7 wk)
- β-hCG increases less in ectopic pregnancy
- Correlation with vaginal US increases predictive value
Imaging
- Ultrasonographic evidence of IUP makes ectopic pregnancy less likely:
- Heterotopic pregnancies are possible
- Positive IUP is indicated by double-ringed gestational sac, yolk sac, or fetal pole, and heartbeat seen in uterus
- Transvaginal US; visualization of gestational sac at 5 wk, cardiac activity at 6.5 wk
- Transabdominal US; visualization of gestational sac at 5–6 wk, cardiac activity at 8 wk
- Complex adnexal mass and fluid in cul-de-sac seen in 22% of ectopics and has 94% positive predictive value when present
- Positive pregnancy test with no confirmed IUP and fluid in pelvis; high risk for bleeding ectopic pregnancy
Diagnostic Procedures/Surgery
- US in conjunction with quantitative β-hCG
- Patients with β-hCG levels >6,500 mIU/L and no intrauterine gestational sac seen on US have 100% chance of having ectopic pregnancy
- Patients with β-hCG levels >6,500 mIU/L with intrauterine gestational sacs present have 94% chance of having normal pregnancy
- Patients with β-hCG <2,000 mIU/L are too early to have gestational sac seen by abdominal US and thus cannot be ruled out for ectopic pregnancy
- Patients with β-hCG >2,000 and <6,500 mIU/L should have IUP visualized on transvaginal US; suspect ectopic pregnancy if IUP is absent
- Discriminatory hCG value for transvaginal US is between 1,500 and 3,000 mIU/mL
- Culdocentesis to evaluate for intraperitoneal blood if US is unavailable
DIFFERENTIAL DIAGNOSIS
- Positive pregnancy test with vaginal bleeding:
- Spontaneous abortion
- Cervicitis
- Trauma
- Positive pregnancy test with no evidence of IUP:
- Completed spontaneous abortion
- Early threatened abortion
- Positive pregnancy test with evidence of IUP, abdominal pain, or adnexal tenderness:
- Septic abortion
- Threatened abortion
- Ruptured corpus luteal or ovarian cyst
- Ovarian torsion
- UTI
- Nephrolithiasis
- Gastroenteritis
- Appendicitis
- Heterotopic pregnancy (IUP + ectopic)
- PID
TREATMENT